Literature DB >> 3579359

Dapsone as initial treatment in superficial pemphigus. Report of nine cases.

N Basset, B Guillot, B Michel, J Meynadier, J J Guilhou.   

Abstract

Nine cases of superficial pemphigus that were treated by dapsone as the initial mode of therapy are reported. Five patients, all having low or negative serum anti-intercellular cement substance antibody titers, responded dramatically, while the other four patients, showing high titers of anti-intercellular cement substance antibodies, did not respond to this treatment. Complications of therapy were observed in three cases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3579359

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  6 in total

1.  Pemphigus foliaceus.

Authors:  C Galambrun; F Cambazard; C Clavel; P Versini; J L Stéphan
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

Review 2.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Dermatol Clin       Date:  2011-10       Impact factor: 3.478

Review 3.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Immunol Allergy Clin North Am       Date:  2012-04-18       Impact factor: 3.479

4.  Therapy of autoimmune bullous diseases.

Authors:  Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

5.  Pemphigus foliaceus masquerading as IgA pemphigus and responding to dapsone.

Authors:  Manas Chatterjee; Shweta Meru; Biju Vasudevan; Prabal Deb; Nikhil Moorchung
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

6.  The management of oral pemphigus vulgaris with systemic corticosteroid and dapsone.

Authors:  Arash Azizi; Shirin Lawaf
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2008-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.